ArticleJournal of substance abuse treatment2021
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.
Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 33 citations in OpenAlex.
- Racial and Ethnic Differences in Long-Term Outcomes among Individuals with Opioid Use Disorder at Opioid Treatment Programs.Journal of racial and ethnic health disparities · 2026Trial
- Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States.Addiction (Abingdon, England) · 2025Article
- Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence.BMC public health · 2024Article
- Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement.JAMA network open · 2024Article
- Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA.Addiction (Abingdon, England) · 2023Article
- Sexual Health and Psychological Well-Being of Women: A Systematic Review.Healthcare (Basel, Switzerland) · 2023Review
- Article
- Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature.Frontiers in public health · 2023Article
- Primary, Secondary, and Tertiary Prevention of Substance Use Disorders through Socioecological Strategies.NAM perspectives · 2023Review
- Opiate maintenance patients' attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections.Frontiers in psychiatry · 2023Article
- A COVID-19 Survey among People Who Use Drugs in Norway.International journal of environmental research and public health · 2022Article
- Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2022Article
- Social distancing and changes in drug use: Results from a cross-sectional study during the COVID-19 pandemic in Brazil.Frontiers in psychiatry · 2022Article
- For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic.Substance abuse : research and treatment · 2022Article
- Article
- Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection.British journal of anaesthesia · 2021Article
- Effect of COVID-19 on Pet Food Bank Servicing: Quantifying Numbers of Clients Serviced in the Vancouver Downtown Eastside, British Columbia, Canada.Frontiers in veterinary science · 2021Article
- Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics.Journal of psychoactive drugsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
objectiveThe COVID-19 pandemic has exacerbated health disparities, particularly among at-risk people with opioid use disorder (OUD). We sought to characterize the direct and indirect impacts of COVID-19 on this group to understand how the pandemic has affected this group, this group's public health response to COVID-19, and whether there were differences by race/ethnicity.
methodsThis study recruited its sample from a drug treatment setting in the northeast region of the United States. We surveyed 110 individuals on methadone as treatment for OUD and assessed COVID-19-related impacts on their health behaviors and other indices of social, physical, and mental well-being, including sexual health behaviors, substance use, mental health status, health care access, income, and employment.
resultsOur findings highlight overall increases in depression, anxiety, loneliness, and frustration among the sample of people with OUD; the study also observed decreases in financial stability. Significant differences between groups indicated a greater financial burden among racial-ethnic minorities; this subgroup also reported greater direct adverse effects of COVID-19, including being more concerned about contracting COVID-19, not being able to get a COVID-19 test, and knowing someone who had died from COVID-19. A greater proportion of Whites indicated increases in alcohol consumption and non-prescription drug use than did racial-ethnic minorities.
conclusionsTreatment providers must be vigilant in managing direct and indirect outcomes of COVID-19 among people with OUD. Findings highlight the need to develop culturally competent, differentiated interventions in partnership with community-based organizations to meet the unique challenges that the COVID-19 pandemic presents for people in treatment for OUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.